nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—ADRB1—coronary artery disease	0.119	0.358	CbGaD
Epinephrine—TNF—coronary artery disease	0.113	0.34	CbGaD
Epinephrine—ADRB2—coronary artery disease	0.0998	0.301	CbGaD
Epinephrine—ADRB3—Timolol—coronary artery disease	0.0607	0.149	CbGbCtD
Epinephrine—ADRB2—Penbutolol—coronary artery disease	0.0352	0.0864	CbGbCtD
Epinephrine—ADRB1—Penbutolol—coronary artery disease	0.0347	0.0851	CbGbCtD
Epinephrine—SLC22A5—Niacin—coronary artery disease	0.028	0.0687	CbGbCtD
Epinephrine—ADRB2—Timolol—coronary artery disease	0.0248	0.0609	CbGbCtD
Epinephrine—ADRB1—Timolol—coronary artery disease	0.0244	0.06	CbGbCtD
Epinephrine—SLC22A5—Furosemide—coronary artery disease	0.0184	0.0452	CbGbCtD
Epinephrine—CYP2C9—Fenofibrate—coronary artery disease	0.0139	0.0342	CbGbCtD
Epinephrine—CYP1A2—Gemfibrozil—coronary artery disease	0.0124	0.0303	CbGbCtD
Epinephrine—CYP2C9—Gemfibrozil—coronary artery disease	0.0111	0.0273	CbGbCtD
Epinephrine—CYP1A2—Clopidogrel—coronary artery disease	0.0107	0.0263	CbGbCtD
Epinephrine—CYP2C9—Clopidogrel—coronary artery disease	0.00966	0.0237	CbGbCtD
Epinephrine—CYP3A4—Ticagrelor—coronary artery disease	0.00909	0.0223	CbGbCtD
Epinephrine—CYP2C9—Pitavastatin—coronary artery disease	0.00844	0.0207	CbGbCtD
Epinephrine—CYP2C9—Valsartan—coronary artery disease	0.00821	0.0202	CbGbCtD
Epinephrine—CYP3A4—Fenofibrate—coronary artery disease	0.0081	0.0199	CbGbCtD
Epinephrine—CYP3A4—Gemfibrozil—coronary artery disease	0.00648	0.0159	CbGbCtD
Epinephrine—CYP2C9—Rosuvastatin—coronary artery disease	0.00622	0.0153	CbGbCtD
Epinephrine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00606	0.0149	CbGbCtD
Epinephrine—CYP2C9—Simvastatin—coronary artery disease	0.00578	0.0142	CbGbCtD
Epinephrine—CYP2C9—Pravastatin—coronary artery disease	0.00566	0.0139	CbGbCtD
Epinephrine—CYP2C9—Lovastatin—coronary artery disease	0.00566	0.0139	CbGbCtD
Epinephrine—CYP3A4—Clopidogrel—coronary artery disease	0.00561	0.0138	CbGbCtD
Epinephrine—CYP1A2—Losartan—coronary artery disease	0.00523	0.0128	CbGbCtD
Epinephrine—CYP3A4—Eplerenone—coronary artery disease	0.00522	0.0128	CbGbCtD
Epinephrine—CYP2C9—Atorvastatin—coronary artery disease	0.00516	0.0127	CbGbCtD
Epinephrine—CYP2C9—Losartan—coronary artery disease	0.00472	0.0116	CbGbCtD
Epinephrine—CYP3A4—Enalapril—coronary artery disease	0.00465	0.0114	CbGbCtD
Epinephrine—CYP3A4—Rosuvastatin—coronary artery disease	0.00362	0.00888	CbGbCtD
Epinephrine—CYP3A4—Ezetimibe—coronary artery disease	0.00362	0.00888	CbGbCtD
Epinephrine—CYP2C9—cardial valve—coronary artery disease	0.00353	0.237	CbGeAlD
Epinephrine—CYP3A4—Simvastatin—coronary artery disease	0.00336	0.00826	CbGbCtD
Epinephrine—CYP3A4—Pravastatin—coronary artery disease	0.00329	0.00808	CbGbCtD
Epinephrine—CYP3A4—Lovastatin—coronary artery disease	0.00329	0.00808	CbGbCtD
Epinephrine—CYP3A4—Atorvastatin—coronary artery disease	0.003	0.00736	CbGbCtD
Epinephrine—CYP3A4—Losartan—coronary artery disease	0.00274	0.00673	CbGbCtD
Epinephrine—ADRBK1—myocardium—coronary artery disease	0.00108	0.0722	CbGeAlD
Epinephrine—TNF—blood—coronary artery disease	0.000975	0.0654	CbGeAlD
Epinephrine—ADRBK1—heart—coronary artery disease	0.000751	0.0504	CbGeAlD
Epinephrine—PAH—blood—coronary artery disease	0.000734	0.0492	CbGeAlD
Epinephrine—ADRBK1—cardiovascular system—coronary artery disease	0.000708	0.0475	CbGeAlD
Epinephrine—ADRBK1—blood—coronary artery disease	0.00056	0.0376	CbGeAlD
Epinephrine—ADRB1—cardiac ventricle—coronary artery disease	0.000478	0.0321	CbGeAlD
Epinephrine—ADRB1—myocardium—coronary artery disease	0.00045	0.0302	CbGeAlD
Epinephrine—ADRA2C—cardiac ventricle—coronary artery disease	0.00036	0.0242	CbGeAlD
Epinephrine—SLC22A5—cardiac ventricle—coronary artery disease	0.000345	0.0232	CbGeAlD
Epinephrine—ADRA2C—myocardium—coronary artery disease	0.000339	0.0227	CbGeAlD
Epinephrine—Isoprenaline—MAPK1—coronary artery disease	0.000326	0.085	CrCbGaD
Epinephrine—SLC22A5—myocardium—coronary artery disease	0.000325	0.0218	CbGeAlD
Epinephrine—ADRB1—heart—coronary artery disease	0.000314	0.0211	CbGeAlD
Epinephrine—Orciprenaline—ADRB2—coronary artery disease	0.000311	0.0811	CrCbGaD
Epinephrine—Pirbuterol—ADRB1—coronary artery disease	0.000298	0.0777	CrCbGaD
Epinephrine—ADRB1—cardiovascular system—coronary artery disease	0.000296	0.0199	CbGeAlD
Epinephrine—ADRB1—cardiac atrium—coronary artery disease	0.000269	0.018	CbGeAlD
Epinephrine—Pirbuterol—ADRB2—coronary artery disease	0.000251	0.0654	CrCbGaD
Epinephrine—ADRA1A—heart—coronary artery disease	0.000248	0.0167	CbGeAlD
Epinephrine—SLC22A1—blood—coronary artery disease	0.000243	0.0163	CbGeAlD
Epinephrine—ADRA2C—heart—coronary artery disease	0.000237	0.0159	CbGeAlD
Epinephrine—Dipivefrin—ADRB2—coronary artery disease	0.000236	0.0615	CrCbGaD
Epinephrine—ADRA1A—cardiovascular system—coronary artery disease	0.000234	0.0157	CbGeAlD
Epinephrine—Isoetarine—ADRB1—coronary artery disease	0.000234	0.061	CrCbGaD
Epinephrine—SLC22A5—heart—coronary artery disease	0.000227	0.0152	CbGeAlD
Epinephrine—Terbutaline—ADRB2—coronary artery disease	0.000204	0.0533	CrCbGaD
Epinephrine—ADRA2C—cardiac atrium—coronary artery disease	0.000202	0.0136	CbGeAlD
Epinephrine—Isoetarine—ADRB2—coronary artery disease	0.000197	0.0513	CrCbGaD
Epinephrine—CYP2C9—heart—coronary artery disease	0.000195	0.0131	CbGeAlD
Epinephrine—SLC22A5—cardiac atrium—coronary artery disease	0.000194	0.013	CbGeAlD
Epinephrine—ADRA2A—heart—coronary artery disease	0.000189	0.0127	CbGeAlD
Epinephrine—Arbutamine—ADRB1—coronary artery disease	0.000186	0.0485	CrCbGaD
Epinephrine—ADRA1A—blood—coronary artery disease	0.000185	0.0124	CbGeAlD
Epinephrine—CYP2C9—cardiovascular system—coronary artery disease	0.000184	0.0123	CbGeAlD
Epinephrine—Salbutamol—ADRB1—coronary artery disease	0.000181	0.0471	CrCbGaD
Epinephrine—ADRA2C—blood—coronary artery disease	0.000177	0.0118	CbGeAlD
Epinephrine—SLC22A5—blood—coronary artery disease	0.000169	0.0113	CbGeAlD
Epinephrine—Norepinephrine—SLC22A3—coronary artery disease	0.000165	0.0431	CrCbGaD
Epinephrine—ADRA2A—cardiac atrium—coronary artery disease	0.000161	0.0108	CbGeAlD
Epinephrine—Arbutamine—ADRB2—coronary artery disease	0.000157	0.0408	CrCbGaD
Epinephrine—Dopamine—SLC22A3—coronary artery disease	0.000154	0.0401	CrCbGaD
Epinephrine—CYP1A2—blood—coronary artery disease	0.000153	0.0103	CbGeAlD
Epinephrine—Salbutamol—ADRB2—coronary artery disease	0.000152	0.0396	CrCbGaD
Epinephrine—Agitation—Trandolapril—coronary artery disease	0.000147	0.00129	CcSEcCtD
Epinephrine—Chest pain—Valsartan—coronary artery disease	0.000147	0.00129	CcSEcCtD
Epinephrine—Agitation—Enalapril—coronary artery disease	0.000147	0.00129	CcSEcCtD
Epinephrine—Sweating—Ramipril—coronary artery disease	0.000147	0.00129	CcSEcCtD
Epinephrine—Paraesthesia—Fenofibrate—coronary artery disease	0.000146	0.00129	CcSEcCtD
Epinephrine—Chest pain—Olmesartan—coronary artery disease	0.000146	0.00128	CcSEcCtD
Epinephrine—Tension—Perindopril—coronary artery disease	0.000146	0.00128	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—coronary artery disease	0.000146	0.00128	CcSEcCtD
Epinephrine—CYP2C9—blood—coronary artery disease	0.000145	0.00976	CbGeAlD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—coronary artery disease	0.000145	0.00127	CcSEcCtD
Epinephrine—Insomnia—Clopidogrel—coronary artery disease	0.000145	0.00127	CcSEcCtD
Epinephrine—Somnolence—Fenofibrate—coronary artery disease	0.000145	0.00127	CcSEcCtD
Epinephrine—Erythema—Furosemide—coronary artery disease	0.000144	0.00127	CcSEcCtD
Epinephrine—Nervousness—Perindopril—coronary artery disease	0.000144	0.00127	CcSEcCtD
Epinephrine—Insomnia—Lovastatin—coronary artery disease	0.000144	0.00127	CcSEcCtD
Epinephrine—Paraesthesia—Clopidogrel—coronary artery disease	0.000144	0.00127	CcSEcCtD
Epinephrine—Sweating—Timolol—coronary artery disease	0.000143	0.00126	CcSEcCtD
Epinephrine—Arrhythmia—Losartan—coronary artery disease	0.000143	0.00126	CcSEcCtD
Epinephrine—Paraesthesia—Lovastatin—coronary artery disease	0.000143	0.00126	CcSEcCtD
Epinephrine—Hypertension—Pravastatin—coronary artery disease	0.000142	0.00125	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Niacin—coronary artery disease	0.000142	0.00125	CcSEcCtD
Epinephrine—Palpitations—Trandolapril—coronary artery disease	0.000142	0.00124	CcSEcCtD
Epinephrine—Dizziness—Gemfibrozil—coronary artery disease	0.000141	0.00124	CcSEcCtD
Epinephrine—Insomnia—Ezetimibe—coronary artery disease	0.000141	0.00124	CcSEcCtD
Epinephrine—Palpitations—Enalapril—coronary artery disease	0.000141	0.00124	CcSEcCtD
Epinephrine—ADRA2A—blood—coronary artery disease	0.000141	0.00945	CbGeAlD
Epinephrine—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.000141	0.00124	CcSEcCtD
Epinephrine—Chest pain—Pravastatin—coronary artery disease	0.00014	0.00123	CcSEcCtD
Epinephrine—Hyperglycaemia—Lisinopril—coronary artery disease	0.00014	0.00123	CcSEcCtD
Epinephrine—Paraesthesia—Ezetimibe—coronary artery disease	0.00014	0.00123	CcSEcCtD
Epinephrine—Erythema—Losartan—coronary artery disease	0.000139	0.00123	CcSEcCtD
Epinephrine—Palpitations—Telmisartan—coronary artery disease	0.000139	0.00122	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.000138	0.00122	CcSEcCtD
Epinephrine—Insomnia—Eplerenone—coronary artery disease	0.000138	0.00122	CcSEcCtD
Epinephrine—Dizziness—Ticagrelor—coronary artery disease	0.000138	0.00121	CcSEcCtD
Epinephrine—Nervous system disorder—Valsartan—coronary artery disease	0.000138	0.00121	CcSEcCtD
Epinephrine—Nervous system disorder—Olmesartan—coronary artery disease	0.000137	0.00121	CcSEcCtD
Epinephrine—Tension—Losartan—coronary artery disease	0.000137	0.0012	CcSEcCtD
Epinephrine—Acute coronary syndrome—Lisinopril—coronary artery disease	0.000137	0.0012	CcSEcCtD
Epinephrine—Skin disorder—Valsartan—coronary artery disease	0.000137	0.0012	CcSEcCtD
Epinephrine—Tachycardia—Olmesartan—coronary artery disease	0.000137	0.0012	CcSEcCtD
Epinephrine—Agitation—Perindopril—coronary artery disease	0.000137	0.0012	CcSEcCtD
Epinephrine—Chest pain—Trandolapril—coronary artery disease	0.000136	0.0012	CcSEcCtD
Epinephrine—Renal failure—Lisinopril—coronary artery disease	0.000136	0.0012	CcSEcCtD
Epinephrine—Skin disorder—Olmesartan—coronary artery disease	0.000136	0.0012	CcSEcCtD
Epinephrine—Myocardial infarction—Lisinopril—coronary artery disease	0.000136	0.0012	CcSEcCtD
Epinephrine—Hypertension—Telmisartan—coronary artery disease	0.000136	0.00119	CcSEcCtD
Epinephrine—Vomiting—Gemfibrozil—coronary artery disease	0.000136	0.00119	CcSEcCtD
Epinephrine—Chest pain—Enalapril—coronary artery disease	0.000136	0.00119	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—coronary artery disease	0.000135	0.00119	CcSEcCtD
Epinephrine—Nervousness—Losartan—coronary artery disease	0.000135	0.00119	CcSEcCtD
Epinephrine—Hyperhidrosis—Olmesartan—coronary artery disease	0.000135	0.00119	CcSEcCtD
Epinephrine—Palpitations—Captopril—coronary artery disease	0.000135	0.00119	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.000135	0.00119	CcSEcCtD
Epinephrine—Insomnia—Simvastatin—coronary artery disease	0.000135	0.00118	CcSEcCtD
Epinephrine—Chest pain—Telmisartan—coronary artery disease	0.000134	0.00118	CcSEcCtD
Epinephrine—Paraesthesia—Simvastatin—coronary artery disease	0.000134	0.00118	CcSEcCtD
Epinephrine—Hallucination—Timolol—coronary artery disease	0.000134	0.00117	CcSEcCtD
Epinephrine—Tachycardia—Niacin—coronary artery disease	0.000133	0.00117	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	0.000133	0.00117	CcSEcCtD
Epinephrine—Sweating—Lisinopril—coronary artery disease	0.000133	0.00117	CcSEcCtD
Epinephrine—Skin disorder—Niacin—coronary artery disease	0.000133	0.00117	CcSEcCtD
Epinephrine—Agitation—Furosemide—coronary artery disease	0.000133	0.00117	CcSEcCtD
Epinephrine—Vomiting—Ticagrelor—coronary artery disease	0.000133	0.00117	CcSEcCtD
Epinephrine—Hyperhidrosis—Niacin—coronary artery disease	0.000132	0.00116	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000132	0.00116	CcSEcCtD
Epinephrine—Palpitations—Perindopril—coronary artery disease	0.000131	0.00115	CcSEcCtD
Epinephrine—Chest pain—Captopril—coronary artery disease	0.00013	0.00115	CcSEcCtD
Epinephrine—Hyperhidrosis—Pravastatin—coronary artery disease	0.00013	0.00114	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000129	0.00113	CcSEcCtD
Epinephrine—Hypertension—Perindopril—coronary artery disease	0.000128	0.00113	CcSEcCtD
Epinephrine—Nervous system disorder—Trandolapril—coronary artery disease	0.000128	0.00113	CcSEcCtD
Epinephrine—Agitation—Losartan—coronary artery disease	0.000128	0.00113	CcSEcCtD
Epinephrine—Tachycardia—Trandolapril—coronary artery disease	0.000128	0.00112	CcSEcCtD
Epinephrine—Flushing—Ramipril—coronary artery disease	0.000127	0.00112	CcSEcCtD
Epinephrine—Insomnia—Valsartan—coronary artery disease	0.000127	0.00112	CcSEcCtD
Epinephrine—Tachycardia—Enalapril—coronary artery disease	0.000127	0.00112	CcSEcCtD
Epinephrine—Skin disorder—Trandolapril—coronary artery disease	0.000127	0.00112	CcSEcCtD
Epinephrine—Nausea—Gemfibrozil—coronary artery disease	0.000127	0.00112	CcSEcCtD
Epinephrine—Insomnia—Olmesartan—coronary artery disease	0.000127	0.00111	CcSEcCtD
Epinephrine—Chest pain—Perindopril—coronary artery disease	0.000126	0.00111	CcSEcCtD
Epinephrine—Hyperhidrosis—Trandolapril—coronary artery disease	0.000126	0.00111	CcSEcCtD
Epinephrine—Paraesthesia—Valsartan—coronary artery disease	0.000126	0.00111	CcSEcCtD
Epinephrine—Nervous system disorder—Telmisartan—coronary artery disease	0.000126	0.00111	CcSEcCtD
Epinephrine—Hyperhidrosis—Enalapril—coronary artery disease	0.000126	0.00111	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	0.000126	0.0011	CcSEcCtD
Epinephrine—Tachycardia—Telmisartan—coronary artery disease	0.000125	0.0011	CcSEcCtD
Epinephrine—Somnolence—Valsartan—coronary artery disease	0.000125	0.0011	CcSEcCtD
Epinephrine—Skin disorder—Telmisartan—coronary artery disease	0.000125	0.0011	CcSEcCtD
Epinephrine—Dizziness—Rosuvastatin—coronary artery disease	0.000124	0.00109	CcSEcCtD
Epinephrine—Hyperhidrosis—Telmisartan—coronary artery disease	0.000124	0.00109	CcSEcCtD
Epinephrine—Nausea—Ticagrelor—coronary artery disease	0.000124	0.00109	CcSEcCtD
Epinephrine—Hallucination—Lisinopril—coronary artery disease	0.000124	0.00109	CcSEcCtD
Epinephrine—Insomnia—Niacin—coronary artery disease	0.000124	0.00109	CcSEcCtD
Epinephrine—Palpitations—Losartan—coronary artery disease	0.000123	0.00108	CcSEcCtD
Epinephrine—Paraesthesia—Niacin—coronary artery disease	0.000123	0.00108	CcSEcCtD
Epinephrine—Arrhythmia—Ramipril—coronary artery disease	0.000123	0.00108	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	0.000122	0.00107	CcSEcCtD
Epinephrine—Tachycardia—Captopril—coronary artery disease	0.000122	0.00107	CcSEcCtD
Epinephrine—Insomnia—Pravastatin—coronary artery disease	0.000122	0.00107	CcSEcCtD
Epinephrine—Somnolence—Niacin—coronary artery disease	0.000122	0.00107	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000121	0.00107	CcSEcCtD
Epinephrine—Paraesthesia—Pravastatin—coronary artery disease	0.000121	0.00106	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000121	0.00106	CcSEcCtD
Epinephrine—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000121	0.00106	CcSEcCtD
Epinephrine—Mental disorder—Ramipril—coronary artery disease	0.00012	0.00106	CcSEcCtD
Epinephrine—Arrhythmia—Timolol—coronary artery disease	0.00012	0.00105	CcSEcCtD
Epinephrine—Erythema—Ramipril—coronary artery disease	0.000119	0.00105	CcSEcCtD
Epinephrine—Nervous system disorder—Perindopril—coronary artery disease	0.000119	0.00105	CcSEcCtD
Epinephrine—Chest pain—Losartan—coronary artery disease	0.000119	0.00104	CcSEcCtD
Epinephrine—Tachycardia—Perindopril—coronary artery disease	0.000118	0.00104	CcSEcCtD
Epinephrine—Insomnia—Trandolapril—coronary artery disease	0.000118	0.00104	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Niacin—coronary artery disease	0.000118	0.00104	CcSEcCtD
Epinephrine—Skin disorder—Perindopril—coronary artery disease	0.000118	0.00104	CcSEcCtD
Epinephrine—Insomnia—Enalapril—coronary artery disease	0.000118	0.00104	CcSEcCtD
Epinephrine—Mental disorder—Timolol—coronary artery disease	0.000118	0.00103	CcSEcCtD
Epinephrine—Paraesthesia—Trandolapril—coronary artery disease	0.000117	0.00103	CcSEcCtD
Epinephrine—Tension—Ramipril—coronary artery disease	0.000117	0.00103	CcSEcCtD
Epinephrine—Hyperhidrosis—Perindopril—coronary artery disease	0.000117	0.00103	CcSEcCtD
Epinephrine—Paraesthesia—Enalapril—coronary artery disease	0.000117	0.00103	CcSEcCtD
Epinephrine—Erythema—Timolol—coronary artery disease	0.000117	0.00103	CcSEcCtD
Epinephrine—Somnolence—Trandolapril—coronary artery disease	0.000116	0.00102	CcSEcCtD
Epinephrine—Insomnia—Telmisartan—coronary artery disease	0.000116	0.00102	CcSEcCtD
Epinephrine—Nervousness—Ramipril—coronary artery disease	0.000116	0.00102	CcSEcCtD
Epinephrine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000116	0.00102	CcSEcCtD
Epinephrine—Somnolence—Enalapril—coronary artery disease	0.000116	0.00102	CcSEcCtD
Epinephrine—Nervous system disorder—Furosemide—coronary artery disease	0.000116	0.00102	CcSEcCtD
Epinephrine—Flushing—Lisinopril—coronary artery disease	0.000116	0.00102	CcSEcCtD
Epinephrine—Paraesthesia—Telmisartan—coronary artery disease	0.000115	0.00101	CcSEcCtD
Epinephrine—Tension—Timolol—coronary artery disease	0.000115	0.00101	CcSEcCtD
Epinephrine—Skin disorder—Furosemide—coronary artery disease	0.000114	0.00101	CcSEcCtD
Epinephrine—Somnolence—Telmisartan—coronary artery disease	0.000114	0.001	CcSEcCtD
Epinephrine—Hyperhidrosis—Furosemide—coronary artery disease	0.000114	0.001	CcSEcCtD
Epinephrine—Nervousness—Timolol—coronary artery disease	0.000113	0.000998	CcSEcCtD
Epinephrine—Insomnia—Captopril—coronary artery disease	0.000113	0.000993	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000113	0.000993	CcSEcCtD
Epinephrine—Paraesthesia—Captopril—coronary artery disease	0.000112	0.000986	CcSEcCtD
Epinephrine—Nausea—Rosuvastatin—coronary artery disease	0.000112	0.000981	CcSEcCtD
Epinephrine—Nervous system disorder—Losartan—coronary artery disease	0.000112	0.000981	CcSEcCtD
Epinephrine—Arrhythmia—Lisinopril—coronary artery disease	0.000111	0.000978	CcSEcCtD
Epinephrine—Somnolence—Captopril—coronary artery disease	0.000111	0.000976	CcSEcCtD
Epinephrine—Tachycardia—Losartan—coronary artery disease	0.000111	0.000976	CcSEcCtD
Epinephrine—CYP3A4—blood—coronary artery disease	0.000111	0.00744	CbGeAlD
Epinephrine—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000111	0.000975	CcSEcCtD
Epinephrine—Hyperhidrosis—Losartan—coronary artery disease	0.00011	0.000967	CcSEcCtD
Epinephrine—Agitation—Ramipril—coronary artery disease	0.00011	0.000966	CcSEcCtD
Epinephrine—Insomnia—Perindopril—coronary artery disease	0.00011	0.000964	CcSEcCtD
Epinephrine—Mental disorder—Lisinopril—coronary artery disease	0.000109	0.000959	CcSEcCtD
Epinephrine—Paraesthesia—Perindopril—coronary artery disease	0.000109	0.000957	CcSEcCtD
Epinephrine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000108	0.000953	CcSEcCtD
Epinephrine—Erythema—Lisinopril—coronary artery disease	0.000108	0.000953	CcSEcCtD
Epinephrine—Dizziness—Fenofibrate—coronary artery disease	0.000108	0.000948	CcSEcCtD
Epinephrine—Somnolence—Perindopril—coronary artery disease	0.000108	0.000948	CcSEcCtD
Epinephrine—Droxidopa—ADRB1—coronary artery disease	0.000107	0.0279	CrCbGaD
Epinephrine—Tension—Lisinopril—coronary artery disease	0.000106	0.000935	CcSEcCtD
Epinephrine—Dizziness—Clopidogrel—coronary artery disease	0.000106	0.000932	CcSEcCtD
Epinephrine—Paraesthesia—Furosemide—coronary artery disease	0.000106	0.000931	CcSEcCtD
Epinephrine—Palpitations—Ramipril—coronary artery disease	0.000106	0.000929	CcSEcCtD
Epinephrine—Dizziness—Lovastatin—coronary artery disease	0.000105	0.000926	CcSEcCtD
Epinephrine—Nervousness—Lisinopril—coronary artery disease	0.000105	0.000926	CcSEcCtD
Epinephrine—Somnolence—Furosemide—coronary artery disease	0.000105	0.000922	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000105	0.000921	CcSEcCtD
Epinephrine—Vomiting—Fenofibrate—coronary artery disease	0.000104	0.000912	CcSEcCtD
Epinephrine—Dizziness—Ezetimibe—coronary artery disease	0.000103	0.000908	CcSEcCtD
Epinephrine—Palpitations—Timolol—coronary artery disease	0.000103	0.000908	CcSEcCtD
Epinephrine—Insomnia—Losartan—coronary artery disease	0.000103	0.000905	CcSEcCtD
Epinephrine—Paraesthesia—Losartan—coronary artery disease	0.000102	0.000898	CcSEcCtD
Epinephrine—Vomiting—Clopidogrel—coronary artery disease	0.000102	0.000896	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000102	0.000895	CcSEcCtD
Epinephrine—Chest pain—Ramipril—coronary artery disease	0.000102	0.000895	CcSEcCtD
Epinephrine—Vomiting—Lovastatin—coronary artery disease	0.000101	0.00089	CcSEcCtD
Epinephrine—Somnolence—Losartan—coronary artery disease	0.000101	0.000889	CcSEcCtD
Epinephrine—Dizziness—Eplerenone—coronary artery disease	0.000101	0.000889	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000101	0.000888	CcSEcCtD
Epinephrine—Hypertension—Timolol—coronary artery disease	0.000101	0.000887	CcSEcCtD
Epinephrine—Chest pain—Timolol—coronary artery disease	9.94e-05	0.000875	CcSEcCtD
Epinephrine—Vomiting—Ezetimibe—coronary artery disease	9.93e-05	0.000873	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.88e-05	0.000869	CcSEcCtD
Epinephrine—Dizziness—Simvastatin—coronary artery disease	9.85e-05	0.000866	CcSEcCtD
Epinephrine—Dopamine—HTR7—coronary artery disease	9.76e-05	0.0255	CrCbGaD
Epinephrine—Isoprenaline—ADRB1—coronary artery disease	9.72e-05	0.0253	CrCbGaD
Epinephrine—Vomiting—Eplerenone—coronary artery disease	9.72e-05	0.000855	CcSEcCtD
Epinephrine—Nausea—Fenofibrate—coronary artery disease	9.68e-05	0.000852	CcSEcCtD
Epinephrine—Palpitations—Lisinopril—coronary artery disease	9.58e-05	0.000842	CcSEcCtD
Epinephrine—Nervous system disorder—Ramipril—coronary artery disease	9.56e-05	0.000841	CcSEcCtD
Epinephrine—Nausea—Clopidogrel—coronary artery disease	9.52e-05	0.000837	CcSEcCtD
Epinephrine—Tachycardia—Ramipril—coronary artery disease	9.52e-05	0.000837	CcSEcCtD
Epinephrine—Skin disorder—Ramipril—coronary artery disease	9.47e-05	0.000833	CcSEcCtD
Epinephrine—Vomiting—Simvastatin—coronary artery disease	9.47e-05	0.000833	CcSEcCtD
Epinephrine—Nausea—Lovastatin—coronary artery disease	9.46e-05	0.000832	CcSEcCtD
Epinephrine—Hyperhidrosis—Ramipril—coronary artery disease	9.43e-05	0.000829	CcSEcCtD
Epinephrine—Nervous system disorder—Timolol—coronary artery disease	9.35e-05	0.000822	CcSEcCtD
Epinephrine—Dizziness—Valsartan—coronary artery disease	9.3e-05	0.000818	CcSEcCtD
Epinephrine—Nausea—Ezetimibe—coronary artery disease	9.27e-05	0.000816	CcSEcCtD
Epinephrine—Skin disorder—Timolol—coronary artery disease	9.26e-05	0.000814	CcSEcCtD
Epinephrine—Dizziness—Olmesartan—coronary artery disease	9.25e-05	0.000814	CcSEcCtD
Epinephrine—Chest pain—Lisinopril—coronary artery disease	9.23e-05	0.000811	CcSEcCtD
Epinephrine—Hyperhidrosis—Timolol—coronary artery disease	9.22e-05	0.00081	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	9.16e-05	0.000806	CcSEcCtD
Epinephrine—Nausea—Eplerenone—coronary artery disease	9.08e-05	0.000798	CcSEcCtD
Epinephrine—Dizziness—Niacin—coronary artery disease	9.04e-05	0.000795	CcSEcCtD
Epinephrine—Norepinephrine—ADRB1—coronary artery disease	9e-05	0.0235	CrCbGaD
Epinephrine—Droxidopa—ADRB2—coronary artery disease	8.99e-05	0.0234	CrCbGaD
Epinephrine—Vomiting—Valsartan—coronary artery disease	8.94e-05	0.000786	CcSEcCtD
Epinephrine—Dizziness—Pravastatin—coronary artery disease	8.9e-05	0.000783	CcSEcCtD
Epinephrine—Vomiting—Olmesartan—coronary artery disease	8.9e-05	0.000782	CcSEcCtD
Epinephrine—Nausea—Simvastatin—coronary artery disease	8.84e-05	0.000778	CcSEcCtD
Epinephrine—Insomnia—Ramipril—coronary artery disease	8.82e-05	0.000776	CcSEcCtD
Epinephrine—Paraesthesia—Ramipril—coronary artery disease	8.76e-05	0.00077	CcSEcCtD
Epinephrine—Vomiting—Niacin—coronary artery disease	8.69e-05	0.000764	CcSEcCtD
Epinephrine—Somnolence—Ramipril—coronary artery disease	8.67e-05	0.000762	CcSEcCtD
Epinephrine—Dizziness—Trandolapril—coronary artery disease	8.64e-05	0.00076	CcSEcCtD
Epinephrine—Tachycardia—Lisinopril—coronary artery disease	8.63e-05	0.000759	CcSEcCtD
Epinephrine—Insomnia—Timolol—coronary artery disease	8.62e-05	0.000758	CcSEcCtD
Epinephrine—Dizziness—Enalapril—coronary artery disease	8.61e-05	0.000757	CcSEcCtD
Epinephrine—Skin disorder—Lisinopril—coronary artery disease	8.59e-05	0.000755	CcSEcCtD
Epinephrine—Paraesthesia—Timolol—coronary artery disease	8.56e-05	0.000753	CcSEcCtD
Epinephrine—Vomiting—Pravastatin—coronary artery disease	8.56e-05	0.000753	CcSEcCtD
Epinephrine—Hyperhidrosis—Lisinopril—coronary artery disease	8.55e-05	0.000752	CcSEcCtD
Epinephrine—Dizziness—Telmisartan—coronary artery disease	8.49e-05	0.000747	CcSEcCtD
Epinephrine—Somnolence—Timolol—coronary artery disease	8.48e-05	0.000745	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Ramipril—coronary artery disease	8.42e-05	0.00074	CcSEcCtD
Epinephrine—Dopamine—ADRB1—coronary artery disease	8.36e-05	0.0218	CrCbGaD
Epinephrine—Nausea—Valsartan—coronary artery disease	8.35e-05	0.000735	CcSEcCtD
Epinephrine—Nausea—Olmesartan—coronary artery disease	8.31e-05	0.000731	CcSEcCtD
Epinephrine—Vomiting—Trandolapril—coronary artery disease	8.31e-05	0.000731	CcSEcCtD
Epinephrine—Vomiting—Enalapril—coronary artery disease	8.28e-05	0.000728	CcSEcCtD
Epinephrine—Dizziness—Captopril—coronary artery disease	8.26e-05	0.000726	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Timolol—coronary artery disease	8.23e-05	0.000724	CcSEcCtD
Epinephrine—Isoprenaline—ADRB2—coronary artery disease	8.17e-05	0.0213	CrCbGaD
Epinephrine—Vomiting—Telmisartan—coronary artery disease	8.17e-05	0.000718	CcSEcCtD
Epinephrine—Nausea—Niacin—coronary artery disease	8.12e-05	0.000714	CcSEcCtD
Epinephrine—Dizziness—Perindopril—coronary artery disease	8.02e-05	0.000705	CcSEcCtD
Epinephrine—Insomnia—Lisinopril—coronary artery disease	8e-05	0.000703	CcSEcCtD
Epinephrine—Nausea—Pravastatin—coronary artery disease	8e-05	0.000703	CcSEcCtD
Epinephrine—Paraesthesia—Lisinopril—coronary artery disease	7.94e-05	0.000698	CcSEcCtD
Epinephrine—Vomiting—Captopril—coronary artery disease	7.94e-05	0.000698	CcSEcCtD
Epinephrine—Somnolence—Lisinopril—coronary artery disease	7.86e-05	0.000691	CcSEcCtD
Epinephrine—Dizziness—Furosemide—coronary artery disease	7.79e-05	0.000685	CcSEcCtD
Epinephrine—Nausea—Trandolapril—coronary artery disease	7.77e-05	0.000683	CcSEcCtD
Epinephrine—Nausea—Enalapril—coronary artery disease	7.73e-05	0.00068	CcSEcCtD
Epinephrine—Vomiting—Perindopril—coronary artery disease	7.71e-05	0.000678	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.64e-05	0.000671	CcSEcCtD
Epinephrine—Nausea—Telmisartan—coronary artery disease	7.63e-05	0.000671	CcSEcCtD
Epinephrine—Norepinephrine—ADRB2—coronary artery disease	7.57e-05	0.0197	CrCbGaD
Epinephrine—Dizziness—Losartan—coronary artery disease	7.52e-05	0.000661	CcSEcCtD
Epinephrine—Vomiting—Furosemide—coronary artery disease	7.49e-05	0.000659	CcSEcCtD
Epinephrine—Nausea—Captopril—coronary artery disease	7.42e-05	0.000652	CcSEcCtD
Epinephrine—Vomiting—Losartan—coronary artery disease	7.23e-05	0.000636	CcSEcCtD
Epinephrine—Nausea—Perindopril—coronary artery disease	7.2e-05	0.000633	CcSEcCtD
Epinephrine—Nausea—Furosemide—coronary artery disease	7e-05	0.000616	CcSEcCtD
Epinephrine—Nausea—Losartan—coronary artery disease	6.76e-05	0.000594	CcSEcCtD
Epinephrine—Dizziness—Ramipril—coronary artery disease	6.45e-05	0.000567	CcSEcCtD
Epinephrine—Dizziness—Timolol—coronary artery disease	6.3e-05	0.000554	CcSEcCtD
Epinephrine—Vomiting—Ramipril—coronary artery disease	6.2e-05	0.000545	CcSEcCtD
Epinephrine—Vomiting—Timolol—coronary artery disease	6.06e-05	0.000533	CcSEcCtD
Epinephrine—Dopamine—CYP2C19—coronary artery disease	6.06e-05	0.0158	CrCbGaD
Epinephrine—Dizziness—Lisinopril—coronary artery disease	5.85e-05	0.000514	CcSEcCtD
Epinephrine—Nausea—Ramipril—coronary artery disease	5.79e-05	0.000509	CcSEcCtD
Epinephrine—Nausea—Timolol—coronary artery disease	5.66e-05	0.000498	CcSEcCtD
Epinephrine—Vomiting—Lisinopril—coronary artery disease	5.62e-05	0.000495	CcSEcCtD
Epinephrine—Nausea—Lisinopril—coronary artery disease	5.25e-05	0.000462	CcSEcCtD
Epinephrine—ADRB2—Signaling Pathways—NOS3—coronary artery disease	1.23e-06	9.52e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	1.23e-06	9.5e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.22e-06	9.49e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.22e-06	9.49e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GOT1—coronary artery disease	1.22e-06	9.49e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GGT1—coronary artery disease	1.22e-06	9.49e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KIT—coronary artery disease	1.22e-06	9.48e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	1.22e-06	9.47e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—JAK2—coronary artery disease	1.22e-06	9.45e-06	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—PIK3CA—coronary artery disease	1.22e-06	9.44e-06	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—coronary artery disease	1.22e-06	9.44e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SERPINE1—coronary artery disease	1.22e-06	9.43e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOB—coronary artery disease	1.22e-06	9.42e-06	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKT1—coronary artery disease	1.21e-06	9.38e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GCLC—coronary artery disease	1.21e-06	9.38e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CETP—coronary artery disease	1.21e-06	9.38e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	1.21e-06	9.37e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	1.2e-06	9.32e-06	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	1.2e-06	9.29e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	1.2e-06	9.28e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SDC1—coronary artery disease	1.2e-06	9.28e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	1.2e-06	9.27e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—JAK2—coronary artery disease	1.19e-06	9.25e-06	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PIK3CA—coronary artery disease	1.19e-06	9.22e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—F2—coronary artery disease	1.19e-06	9.21e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	1.19e-06	9.21e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	1.18e-06	9.18e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	1.18e-06	9.17e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.18e-06	9.17e-06	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	1.18e-06	9.15e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ALB—coronary artery disease	1.18e-06	9.14e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—FGF2—coronary artery disease	1.18e-06	9.13e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	1.17e-06	9.1e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	1.17e-06	9.1e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	1.17e-06	9.06e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	1.17e-06	9.06e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	1.16e-06	9.03e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—POMC—coronary artery disease	1.16e-06	9.03e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	1.16e-06	9e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NOS3—coronary artery disease	1.16e-06	9e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—LPL—coronary artery disease	1.16e-06	9e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	1.16e-06	8.98e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	1.14e-06	8.86e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	1.14e-06	8.83e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	1.14e-06	8.82e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	1.14e-06	8.81e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	1.14e-06	8.8e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GPX1—coronary artery disease	1.13e-06	8.78e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.13e-06	8.76e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.13e-06	8.76e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	1.13e-06	8.75e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—NOS3—coronary artery disease	1.13e-06	8.75e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	1.12e-06	8.68e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	1.11e-06	8.64e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	1.11e-06	8.63e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	1.11e-06	8.61e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.11e-06	8.58e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	1.11e-06	8.57e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CTGF—coronary artery disease	1.1e-06	8.56e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	1.1e-06	8.55e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CD36—coronary artery disease	1.1e-06	8.55e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.1e-06	8.52e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.09e-06	8.48e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GOT2—coronary artery disease	1.09e-06	8.48e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.09e-06	8.45e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.09e-06	8.44e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.09e-06	8.44e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	1.09e-06	8.44e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	1.09e-06	8.44e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.08e-06	8.41e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.08e-06	8.39e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.08e-06	8.39e-06	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.08e-06	8.34e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	1.07e-06	8.31e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CAT—coronary artery disease	1.07e-06	8.29e-06	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.07e-06	8.26e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.07e-06	8.26e-06	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.07e-06	8.26e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	1.06e-06	8.24e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.06e-06	8.2e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.06e-06	8.2e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.06e-06	8.18e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.06e-06	8.18e-06	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—coronary artery disease	1.05e-06	8.17e-06	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	1.05e-06	8.15e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.05e-06	8.13e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.05e-06	8.1e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CASP3—coronary artery disease	1.04e-06	8.08e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.04e-06	8.07e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOB—coronary artery disease	1.04e-06	8.05e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.04e-06	8.04e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.04e-06	8.03e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—coronary artery disease	1.04e-06	8.03e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.03e-06	8e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	1.03e-06	7.99e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	1.03e-06	7.98e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.03e-06	7.97e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	1.02e-06	7.87e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCND1—coronary artery disease	1.01e-06	7.86e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	1.01e-06	7.86e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.01e-06	7.83e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.01e-06	7.8e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.01e-06	7.8e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	9.98e-07	7.73e-06	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	9.95e-07	7.71e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AGT—coronary artery disease	9.93e-07	7.7e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	9.92e-07	7.69e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—LPL—coronary artery disease	9.92e-07	7.69e-06	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	9.9e-07	7.67e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	9.88e-07	7.66e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	9.87e-07	7.65e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	9.86e-07	7.64e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—coronary artery disease	9.85e-07	7.63e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	9.8e-07	7.59e-06	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	9.8e-07	7.59e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	9.77e-07	7.57e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ABCA1—coronary artery disease	9.76e-07	7.56e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOE—coronary artery disease	9.73e-07	7.54e-06	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—coronary artery disease	9.72e-07	7.53e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	9.71e-07	7.52e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GPX1—coronary artery disease	9.68e-07	7.5e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	9.68e-07	7.5e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	9.67e-07	7.5e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	9.64e-07	7.47e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOA1—coronary artery disease	9.62e-07	7.45e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	9.6e-07	7.44e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	9.57e-07	7.42e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	9.55e-07	7.4e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GGT1—coronary artery disease	9.45e-07	7.32e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GOT1—coronary artery disease	9.45e-07	7.32e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	9.45e-07	7.32e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	9.43e-07	7.31e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CD36—coronary artery disease	9.42e-07	7.3e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	9.32e-07	7.22e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	9.31e-07	7.21e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.21e-07	7.14e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	9.17e-07	7.11e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	9.17e-07	7.11e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	9.11e-07	7.06e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	9.04e-07	7.01e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	9.04e-07	7.01e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	9.01e-07	6.98e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	8.99e-07	6.97e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	8.96e-07	6.94e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	8.93e-07	6.92e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTHFR—coronary artery disease	8.93e-07	6.92e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	8.9e-07	6.9e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	8.84e-07	6.86e-06	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	8.7e-07	6.74e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	8.62e-07	6.68e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	8.57e-07	6.64e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTP1—coronary artery disease	8.49e-07	6.58e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AGT—coronary artery disease	8.49e-07	6.58e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARG—coronary artery disease	8.47e-07	6.57e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	8.41e-07	6.52e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	8.39e-07	6.5e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HMOX1—coronary artery disease	8.37e-07	6.49e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	8.37e-07	6.49e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	8.37e-07	6.49e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—POMC—coronary artery disease	8.36e-07	6.48e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOE—coronary artery disease	8.31e-07	6.44e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	8.3e-07	6.43e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CAT—coronary artery disease	8.26e-07	6.4e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	8.24e-07	6.38e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	8.22e-07	6.37e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOA1—coronary artery disease	8.22e-07	6.37e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	8.15e-07	6.31e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	8.14e-07	6.31e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	8.12e-07	6.29e-06	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	8.08e-07	6.27e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	8.06e-07	6.25e-06	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PIK3CA—coronary artery disease	8.04e-07	6.23e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOB—coronary artery disease	8.02e-07	6.21e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	8.01e-07	6.21e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	7.96e-07	6.17e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	7.96e-07	6.17e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	7.9e-07	6.12e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.87e-07	6.1e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	7.82e-07	6.06e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTM1—coronary artery disease	7.8e-07	6.04e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	7.8e-07	6.04e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	7.75e-07	6.01e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	7.68e-07	5.95e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—LPL—coronary artery disease	7.66e-07	5.93e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ALB—coronary artery disease	7.62e-07	5.91e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	7.57e-07	5.87e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	7.56e-07	5.86e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	7.53e-07	5.84e-06	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PIK3CA—coronary artery disease	7.49e-07	5.81e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GPX1—coronary artery disease	7.47e-07	5.79e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	7.41e-07	5.75e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	7.34e-07	5.69e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	7.32e-07	5.67e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—NOS3—coronary artery disease	7.29e-07	5.65e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CD36—coronary artery disease	7.27e-07	5.64e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARG—coronary artery disease	7.24e-07	5.61e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	7.18e-07	5.57e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—POMC—coronary artery disease	7.14e-07	5.54e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	7.06e-07	5.47e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	7e-07	5.42e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	6.91e-07	5.35e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTHFR—coronary artery disease	6.89e-07	5.34e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—coronary artery disease	6.86e-07	5.32e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	6.8e-07	5.27e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	6.71e-07	5.2e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—coronary artery disease	6.67e-07	5.17e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	6.58e-07	5.1e-06	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—coronary artery disease	6.57e-07	5.09e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AGT—coronary artery disease	6.55e-07	5.08e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	6.54e-07	5.07e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ALB—coronary artery disease	6.51e-07	5.05e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	6.43e-07	4.99e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOE—coronary artery disease	6.42e-07	4.97e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—coronary artery disease	6.39e-07	4.95e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	6.35e-07	4.92e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOA1—coronary artery disease	6.34e-07	4.92e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	6.33e-07	4.91e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—coronary artery disease	6.25e-07	4.85e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	6.24e-07	4.84e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NOS3—coronary artery disease	6.23e-07	4.83e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	6.2e-07	4.8e-06	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—coronary artery disease	6.12e-07	4.74e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	6.12e-07	4.74e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—coronary artery disease	6.12e-07	4.74e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	5.79e-07	4.49e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—coronary artery disease	5.77e-07	4.47e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	5.72e-07	4.43e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	5.71e-07	4.43e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—coronary artery disease	5.7e-07	4.42e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	5.7e-07	4.42e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—coronary artery disease	5.64e-07	4.37e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARG—coronary artery disease	5.59e-07	4.33e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—POMC—coronary artery disease	5.51e-07	4.27e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	5.34e-07	4.14e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	5.31e-07	4.11e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	5.26e-07	4.07e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—coronary artery disease	5.19e-07	4.02e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	5.06e-07	3.92e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALB—coronary artery disease	5.03e-07	3.9e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NOS3—coronary artery disease	4.81e-07	3.73e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	4.7e-07	3.64e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	4.67e-07	3.62e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.4e-07	3.41e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	4.34e-07	3.36e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	4.1e-07	3.18e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	3.5e-07	2.72e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—coronary artery disease	3.35e-07	2.6e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—coronary artery disease	2.86e-07	2.22e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.7e-07	2.1e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—coronary artery disease	2.21e-07	1.71e-06	CbGpPWpGaD
